Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.

Gao, Yining; Pan, Jie; Shen, Dingding; Peng, Lisheng; Mao, Zhifeng; Wang, Chunxia; Meng, Huanyu; Zhou, Qinming; Chen, Sheng

Gao, Yining; Pan, Jie; Shen, Dingding; Peng, Lisheng; Mao, Zhifeng; Wang, Chunxia; Meng, Huanyu; Zhou, Qinming; Chen, Sheng.

Afiliação

Gao Y; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China.
Pan J; Department of Neurology, The First Hospital of Jiaxing & The Affiliated Hospital of Jiaxing University, Jiaxing 314001, China.
Shen D; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China.
Peng L; Co-innovation Center of Neuroregeneration, Nantong University, Nantong 226019, China.
Mao Z; Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Wang C; Neuroimmunology Group, KingMed Diagnostic Laboratory, Guangzhou 510310, China.
Meng H; Department of Clinical Medicine, Medical School, Xiangnan University, Chenzhou 423043, China.
Zhou Q; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Ministry of Science and Technology, Jiangsu Simcere Diagnostics Co., Ltd., No. 699-18 Xuanwu Ave, Nanjing 210002, China.
Chen S; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China.

Brain Sci ; 12(6)2022 Jun 13.

Article em En | MEDLINE | ID: mdl-35741658

Palavras-chave

autoimmune encephalitis; immune checkpoint inhibitors; immune-related adverse event; pembrolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google